Clinical trial
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
NCT01317641
Study timeline
Study start (unknown)2011-03-01Date precision: month
Registry last updated2017-03-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
ODM-201DRUG
Sponsors & collaborators
Orion Corporation, Orion Pharmalead sponsor
Endo USA Inc., a Keenova Therapeutics Companycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01317641 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.